Antisynthetase syndrome

Jump to navigation Jump to search

WikiDoc Resources for Antisynthetase syndrome

Articles

Most recent articles on Antisynthetase syndrome

Most cited articles on Antisynthetase syndrome

Review articles on Antisynthetase syndrome

Articles on Antisynthetase syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Antisynthetase syndrome

Images of Antisynthetase syndrome

Photos of Antisynthetase syndrome

Podcasts & MP3s on Antisynthetase syndrome

Videos on Antisynthetase syndrome

Evidence Based Medicine

Cochrane Collaboration on Antisynthetase syndrome

Bandolier on Antisynthetase syndrome

TRIP on Antisynthetase syndrome

Clinical Trials

Ongoing Trials on Antisynthetase syndrome at Clinical Trials.gov

Trial results on Antisynthetase syndrome

Clinical Trials on Antisynthetase syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Antisynthetase syndrome

NICE Guidance on Antisynthetase syndrome

NHS PRODIGY Guidance

FDA on Antisynthetase syndrome

CDC on Antisynthetase syndrome

Books

Books on Antisynthetase syndrome

News

Antisynthetase syndrome in the news

Be alerted to news on Antisynthetase syndrome

News trends on Antisynthetase syndrome

Commentary

Blogs on Antisynthetase syndrome

Definitions

Definitions of Antisynthetase syndrome

Patient Resources / Community

Patient resources on Antisynthetase syndrome

Discussion groups on Antisynthetase syndrome

Patient Handouts on Antisynthetase syndrome

Directions to Hospitals Treating Antisynthetase syndrome

Risk calculators and risk factors for Antisynthetase syndrome

Healthcare Provider Resources

Symptoms of Antisynthetase syndrome

Causes & Risk Factors for Antisynthetase syndrome

Diagnostic studies for Antisynthetase syndrome

Treatment of Antisynthetase syndrome

Continuing Medical Education (CME)

CME Programs on Antisynthetase syndrome

International

Antisynthetase syndrome en Espanol

Antisynthetase syndrome en Francais

Business

Antisynthetase syndrome in the Marketplace

Patents on Antisynthetase syndrome

Experimental / Informatics

List of terms related to Antisynthetase syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Synonyms and keywords:

Overview

Antisynthetase syndrome, an uncommon autoimmune disorder, is characterized by antibodies against aminoacyl-transfer ribonucleic acid synthetases, with various combinations of three cardinal manifestations of interstitial lung disease (ILD), polymyositis, and arthritis. Other features of antisynthetase syndrome may include pyrexia of unknown origin, mechanic's hand (hyperkeratotic skin changes along the lateral surfaces of the digits) and Raynaud's phenomenon. [1] [2]

Till date, nine different anti-aminoacyl t-RNA synthetase (ARS) antibodies have been identified to play a role in the development of antisynthetase syndrome. [1]

Historical Perspective

In 1990, Marguerie et al and coworkers first described antisynthetase syndrome as a triad of polymyositis, interstitial lung disease (ILD), and the presence of myositis-specific autoantibodies to aminoacyl-transfer ribonucleic acid synthetases. [3]

Classification

Pathophysiology

Causes

Differentiating Antisynthetase syndrome from other Diseases

Antisynthetase syndrome may be misdiagnosed as idiopathic interstitial lung disease (ILD) or inflammatory myopathy. This is due to the rarity and lack of awareness of the disease, as well as due to the lack of


Most cases of AS are either misdiagnosed as idiopathic ILD or inflammatory myopathy not only due to the lack of awareness of the disease entity but also due to the lack of facilities for detection of anti-ARS antibodies.

Epidemiology and Demographics

Age

Gender

Race

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

In 2010, Connors et al proposed a formal criteria for the diagnosis of antisynthetase syndrome. This criteria proposed that all patients must have a presence of an anti-aminoacyl tRNA synthetase antibody in addition to one or more of the following clinical features: mechanic’s hands, Raynaud’s phenomenon, myositis, ILD, arthritis, and/or unexplained fever.

In 2011, Solomon et al proposed alternative criteria, which is more strict. This criteria requires the presence of anti-aminoacyl tRNA synthetase antibody plus two major or one major and two minor criteria.

Major criteria includes: Interstitial Lung Disease (not attributable to another cause), and Polymyositis or dermatomyositis.

Minor criteria includes: arthritis, Raynaud’s phenomenon, and mechanic’s hands. [4]

Connors et al (2010) criteria
Required: Presence of an anti-aminoacyl tRNA synthetase antibody
PLUS one or more of the following clinical features:

1) Raynaud’s phenomenon

2) Arthritis

3) Interstitial lung disease

4) Fever (not attributable to another cause)

5) Mechanic’s hands (thickened and cracked skin on hands, particularly at fingertips)

Solomon et al (2011) criteria
Required: Presence of anti-aminoacyl tRNA synthetase antibody
PLUS two major or one major and two minor criteria:


Major:

1) Interstitial Lung Disease (not attributable to another cause)

2) Polymyositis or dermatomyositis


Minor:

1) Arthritis

2) Raynaud’s phenomenon

3) Mechanic’s hands

Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

As antisynthetase syndrome is associated with interstitial lung disease, and therefore, high resolution computed tomography (HRCT) plays an important role in its work up, as well as to monitor the disease activity. Radiographic features seen on HRCT at the initial diagnosis include traction bronchiectasis, ground glass opacities and reticulation. [4]

Other Diagnostic Studies

Treatment

Medical Therapy

Various immunosuppressive agents, such as azathioprine, mycophenolate mofetil, and/or tacrolimus, are used in the treatment of antisynthetase syndrome. Additionally, corticosteroids may be added for management of the myositis and pulmonary manifestations of anti-synthetase syndrome. The choice of immunosuppressive agent is dependent on the practitioner and is based on the potential risks of therapy as no agent is superior to the other.

Prednisone and azathioprine or mycophenolate mofetil may be used in patients with anti-synthetase syndrome related ILD. In addition to that, tacrolimus may be added for rapid disease control in more severe cases of ILD.

In patients with severe progressive or refractory ILD, rituximab may be added; while cyclophosphamide is reserved for those with acute respiratory distress syndrome.

The physician must also been on the lookout for other co-morbid conditions associated with antisynthetase syndrome i.e. pulmonary hypertension and screening for malignancies. [4]

Surgery

Prevention

References

  1. 1.0 1.1 Maturu VN, Lakshman A, Bal A, Dhir V, Sharma A, Garg M; et al. (2016). "Antisynthetase syndrome: An under-recognized cause of interstitial lung disease". Lung India. 33 (1): 20–6. doi:10.4103/0970-2113.173055. PMC 4748659. PMID 26933302.
  2. Robinson D, Scholz B (2020). "The antisynthetase syndrome". Proc (Bayl Univ Med Cent). 33 (3): 401–403. doi:10.1080/08998280.2020.1764818. PMC 7340408 Check |pmc= value (help). PMID 32675964 Check |pmid= value (help).
  3. Devi HG, Pasha MM, Padmaja MS, Halappa S (2016). "Antisynthetase Syndrome: A Rare Cause for ILD". J Clin Diagn Res. 10 (3): OD08–9. doi:10.7860/JCDR/2016/16872.7361. PMC 4843302. PMID 27134916.
  4. 4.0 4.1 4.2 Witt LJ, Curran JJ, Strek ME (2016). "The Diagnosis and Treatment of Antisynthetase Syndrome". Clin Pulm Med. 23 (5): 218–226. doi:10.1097/CPM.0000000000000171. PMC 5006392. PMID 27594777.